Control of renal uric acid excretion and gout

Current Opinion in Rheumatology

Volumn 20, Issue 2, 2008, Pages 192-197

  Taniguchi, Atsuo ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Gout; Hyperuricemia; Transporter; Urate; Uromodulin

Indexed keywords

ALLOPURINOL; BENZBROMARONE; BUTYRIC ACID; LACTIC ACID; LOSARTAN; PROBENECID; PYRAZINAMIDE; SULFINPYRAZONE; URATE;

DIABETIC KETOACIDOSIS; DISEASE CONTROL; DISEASE COURSE; DRUG MECHANISM; GENETIC POLYMORPHISM; GOUT; HEREDITY; HUMAN; HYPERURICEMIA; KIDNEY DISEASE; KIDNEY DISTAL TUBULE; KIDNEY TUBULE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALT LOSING NEPHRITIS; SEX DIFFERENCE; UPREGULATION; URIC ACID BLOOD LEVEL; URIC ACID NEPHROPATHY; URIC ACID URINE LEVEL;

GENETIC PREDISPOSITION TO DISEASE; GOUT; HUMANS; HYPERURICEMIA; KIDNEY TUBULES, PROXIMAL; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; URIC ACID;

EID: 40349096090     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3282f33f87     Document Type: Review

References (45)

1. Becker MA. The biochemistry of gout. In: Wortmann RL, Schumacher R Jr, Becker MA, Ryan LM, editors. Crystal-induced arthropathies: gout, pseudogout and apatite-associated syndromes. New York: Taylor & Francis; 2006. pp. 189-212.
2. Perez-Ruiz F, Calabozo M, Erauskin GG, et al. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum 2002; 47:610-613.
3. Terkeltaub R, Bushinsky DA, Becker MA. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther 2006; 8 (Suppl 1):S4. Current understanding of hyperuricemia with urate underexcretion is extensively reviewed.
4. Roch-Ramel F, Guisan B. Renal transport of urate in humans. News Physiol Sci 1999; 14:80-84.
5. Mount DB. Molecular physiology and the four-component model of renal urate transport. Curr Opin Nephrol Hypertens 2005; 14:460-463.
6. Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417:447-452.
7. Anzai N, Kanai Y, Endou H. New insights into renal transport of urate. Curr Opin Rheumatol 2007; 19:151-157. This is an extensive and excellent review of the urate transport in kidney.
8. Ekaratanawong S, Anzai N, Jutabha P, et al. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 2004; 94:297-304.
9. Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 2005; 20:125-133.
10. Jutabha P, Kanai Y, Hosoyamada M, et al. Identification of a novel voltagedriven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem 2003; 278:27930-27938.
11. Van Aubel RA, Smeets PH, van den Heuvel JJ, Russel FG. Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am J Physiol Renal Physiol 2005; 288:F327-F333.
12. Miyazaki H, Anzai N, Ekaratanawong S, et al. Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol 2005; 16:3498-3506.
13. Cunningham R, Brazie M, Kanumuru S, et al. Sodium-hydrogen exchanger regulatory factor-1 interacts withmouse urate transporter 1 to regulate renal proximal tubule uric acid transport. J Am Soc Nephrol 2007; 18:1419-1425.
14. Lipkowitz MS, Leal-Pinto E, Cohen BE, Abramson RG. Galectin 9 is the sugar-regulated urate transporter/channel UAT. Glycoconj J 2004; 19:491-498.
15. Buist SC, Cherrington NJ, Choudhuri S, et al. Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 2002; 301:145-151.
16. Rizwan AN, Burckhardt G. Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 2007; 24:450-470. This is an extensive review about the roles of the organic anion transporters in physiological and pathological conditions.
17. Ljubojevic M, Herak-Kramberger CM, Hagos Y, et al. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol 2004; 287:F124-F138.
18. Hosoyamada M, Ichida K, Enomoto A, et al. Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol 2004; 15:261-268.
19. Li T, Walsh JR, Ghishan FK, Bai L. Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter. Biochim Biophys Acta 2004; 1681:53-58.
20. Mount DB, Kwon CY, Zandi-Nejad K. Renal urate transport. Rheum Dis Clin North Am 2006; 32:313-331.
21. Gopal E, Fei YJ, Sugawara M, et al. Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate. J Biol Chem 2004; 279:44522-44532.
22. Srinivas SR, Gopal E, Zhuang L, et al. Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2). Biochem J 2005; 392:655-664.
23. Gopal E, Umapathy NS, Martin PM, et al. Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney. Biochim Biophys Acta 2007; 1768:2690-2697. This paper shows the localization of SMCT1/2 and provides evidence of the transport of lactate via these molecules.
24. Emmerson BT, Nagel SL, Duffy DL, Martin NG. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 1992; 51:375-377.
25. Taniguchi A, Urano W, Yamanaka M, et al. A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. Arthritis Rheum 2005; 52:2576-2577.
26. Ichida K, Hosoyamada M, Hisatome I, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan - influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004; 15:164-173.
27. Komoda F, Sekine T, Inatomi J, et al. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol 2004; 19:728-733.
28. Graessler J, Graessler A, Unger S, et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006; 54:292-300.
29. Vázquez-Mellado J, Jimenez-Vaca AL, Cuevas-Covarrubias S, et al. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 2007; 46:215-219.
30. Vazquez-Mellado J, Alvarado-Romano V, Burgos-Vargas R, et al. Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid. J Clin Pathol 2007; 60:947-948.
31. Iwai N, Mino Y, Hosoyamada M, et al. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int 2004; 66:935-944.
32. Shima Y, Teruya K, Ohta H. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 2006; 79:2234-2237.
33. Kamatani N, Moritani M, Yamanaka H, et al. Localization of a gene for familial juvenile hyperuricemic nephropathy causing underexcretion-type gout to 16p12 by genome-wide linkage analysis of a large family. Arthritis Rheum 2000; 43:925-929.
34. Stiburkova B, Majewski J, Sebesta I, et al. Familial juvenile hyperuricemic nephropathy: localization of the gene on chromosome 16p11.2 and evidence for genetic heterogeneity. Am J Hum Genet 2000; 66:1989-1994.
35. Hart TC, Gorry MC, Hart PS, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 2002; 39:882-892.
36. Bernascone I, Vavassori S, Di Pentima A, et al. Defective intracellular trafficking of uromodulin mutant isoforms. Traffic 2006; 7:1567-1579.
37. Jennings P, Aydin S, Kotanko P, et al. Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy. J Am Soc Nephrol 2007; 18:264-273.
38. Vylet'al P, Kublova M, Kalbacova M, et al. Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int 2006; 70:1155-1169. A comprehensive study of the FJHN/MCKD phenotype using 19 families is described.
39. Kudo E, Kamatani N, Tezuka O, et al. Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families. Kidney Int 2004; 65:1589-1597.
40. Bachmann S, Mutig K, Bates J, et al. Renal effects of Tamm-Horsfall protein (uromodulin) deficiency in mice. Am J Physiol Renal Physiol 2005; 288:F559-F567.
41. Gersch M, Mutig K, Bachmann S, et al. Is salt-wasting the long awaited answer to the hyperuricaemia seen in uromodulin storage diseases? Nephrol Dial Transplant 2006; 21:2028-2029.
42. Chabardes-Garonne D, Mejean A, Aude JC, et al. A panoramic view of gene expression in the human kidney. Proc Natl Acad Sci U S A 2003; 100:13710-13715.
43. Bingham C, Ellard S, van't Hoff WG, et al. Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutation. Kidney Int 2003; 63:1645-1651.
44. Gresh L, Fischer E, Reimann A, et al. A transcriptional network in polycystic kidney disease. EMBO J 2004; 23:1657-1668.
45. Hodanova K, Majewski J, Kublova M, et al. Mapping of a new candidate locus for uromodulin-associated kidney disease (UAKD) to chromosome 1q41. Kidney Int 2005; 68:1472-1482.